Safety profile of <i>Helicobacter pylori</i> eradication treatments: literature review and updated data of the European Registry on <i>Helicobacter pylori</i> management (Hp-EuReg)-Reference-Cited by-同舟云学术

Safety profile of Helicobacter pylori eradication treatments: literature review and updated data of the European Registry on Helicobacter pylori management (Hp-EuReg)

Published:2024-04-03 Issue:5 Volume:23 Page:553-564
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Luzko Irina¹,P. Nyssen Olga²,Moreira Leticia¹,Gisbert Javier P.²

Affiliation:

1. Hospital Clínic de Barcelona, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBERehd), IDIBAPS (Institut d’Investigacions Biomèdiques August Pi i Sunyer), University of Barcelona, Barcelona, Spain

2. Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS‐Princesa), Universidad Autónoma de Madrid (UAM), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2024.2338245

Reference58 articles.

1. Kyoto global consensus report onHelicobacter pylorigastritis

2. Extra-Gastric Manifestations of Helicobacter pylori Infection

3. V Conferencia Española de Consenso sobre el tratamiento de la infección por Helicobacter pylori

4. Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin

5. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Azobenzenesulfonamide Carbonic Anhydrase Inhibitors as New Weapons to Fight Helicobacter pylori: Synthesis, Bioactivity Evaluation, In Vivo Toxicity, and Computational Studies;Pharmaceuticals;2024-08-05